PureTech Health (LSE:PRTC): Does An FDA Fast Track Tag Change Its Funding Plan This Week?

PureTech Health (LSE:PRTC): Does An FDA Fast Track Tag Change Its Funding Plan This Week? →

Highlights The FDA granted Fast Track status to Gallop Oncology's antibody in relapsed high-risk MDS. A successful meeting with the FDA supports moving into a randomised mid-stage trial. PureTech intends to raise external capital for Gallop…